Clitocybe nuda activates dendritic cells and acts as A DNA vaccine adjuvant

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chen, Mei Hsing ^a   Li, Wei Sung ^a   Lue, Yun Sheng ^a   Chu, Ching Liang ^b   Pan, I Hong ^c   Ko, Ching Huai ^c   Chen, Der Yuan ^d,e,f   Lin, Ching Hsiung ^g   Lin, Sheng Hao ^d,g   Chang, Chih Peng ^h   Lin, Chi Chen ^d,f  

^a FISHERIES RESEARCH INSTITUTE   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^h NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CLITOCYBE NUDA WATER EXTRACT; DNA VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CELL MATURATION; CLITOCYBE NUDA; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; EDIBLE MUSHROOM; ENZYME ACTIVITY; FEMALE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84884246901     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/761454     Document Type: Article

References (64)

1. Steinman R. M., Decisions about dendritic cells: past, present, and future. Annual Review of Immunology 2012 30 1 22 2-s2.0-84857793524 10.1146/annurev-immunol-100311-102839
2. Hopkins R. A., Connolly J. E., The specialized roles of immature and mature dendritic cells in antigen cross-presentation. Immunologic Research 2012 53 1-3 91 107 2-s2.0-84858739920 10.1007/s12026-012-8300-z
3. Hivroz C., Chemin K., Tourret M., Bohineust A., Crosstalk between T lymphocytes and dendritic cells. Critical Reviews in Immunology 2012 32 2 139 155
4. Hanke N., Alizadeh D., Katsanis E., Larmonier N., Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy. Critical Reviews in Immunology 2013 33 1 1 21
5. Roy R. M., Klein B. S., Dendritic cells in antifungal immunity and vaccine design. Cell Host & Microbe 2012 11 5 436 446
6. Hubbell J. A., Thomas S. N., Swartz M. A., Materials engineering for immunomodulation. Nature 2009 462 7272 449 460 2-s2.0-70849093813 10.1038/nature08604
7. Chang S. T., Cheung P. C. K., Overview of mushroom cultivation and utilization as functional foods. Mushrooms as Functional Foods 2008 New Jersey, NJ, USA John Wiley & Sons 1 33
8. Guillamón E., García-Lafuente A., Lozano M., D'Arrigo M., Rostagno M. A., Villares A., Martínez J. A., Edible mushrooms: roles in the prevention of cardiovascular diseases. Fitoterapia 2010 81 7 715 723
9. Yu S., Weaver V., Martin K., Cantorna M. T., The effects of whole mushrooms during inflammation. BMC Immunology 2009 10, article 12 2-s2.0-61749103277 10.1186/1471-2172-10-12
10. Lindequist U., Niedermeyer T. H. J., Jülich W.-D., The pharmacological potential of mushrooms. Evidence-Based Complementary and Alternative Medicine 2005 2 3 285 299 2-s2.0-24344469750 10.1093/ecam/neh107
11. Hsu H.-Y., Hua K.-F., Lin C.-C., Lin C.-H., Hsu J., Wong C.-H., Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways. Journal of Immunology 2004 173 10 5989 5999 2-s2.0-8444226278
12. Ko J.-L., Hsu C.-I., Lin R.-H., Kao C.-L., Lin J.-Y., A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom, Flammulina velutipes and its complete amino acid sequence. European Journal of Biochemistry 1995 228 2 244 249 2-s2.0-0028956911 10.1111/j.1432-1033.1995.tb20256.x
13. Barros L., Venturini B. A., Baptista P., Estevinho L. M., Ferreira I. C. F. R., Chemical composition and biological properties of Portuguese wild mushrooms: a comprehensive study. Journal of Agricultural and Food Chemistry 2008 56 10 3856 3862 2-s2.0-45549101213 10.1021/jf8003114
14. Chen J.-T., Huang J.-W., Control of plant diseases with secondary metabolite of Clitocybe nuda. New Biotechnology 2009 26 3-4 193 198 2-s2.0-71749092260 10.1016/j.nbt.2009.08.012
15. Chen J. T., Su H. J., Huang J. W., Isolation and identification of secondary metabolites of Clitocybenuda inhibition of zoospore germination of Phytophthoracapsici. Journal of Agricultural and Food Chemistry 2012 60 30 7341 7344
16. Dulger B., Ergul C. C., Gucin F., Antimicrobial activity of the macrofungus Lepista nuda. Fitoterapia 2002 73 7-8 695 697 2-s2.0-0036915765 10.1016/S0367-326X(02)00233-2
17. Mercan N., Duru M. E., Turko Glu A., Gezer K., Kivrak I., Turko Glu H., Antioxidant and antimicrobial properties of ethanolic extract from Lepista nuda (Bull.) Cooke. Annals of Microbiology 2006 56 4 339 344 2-s2.0-62549158420 10.1007/BF03175028
18. Murcia M. A., Martínez-Tomé M., Jiménez A. M., Vera A. M., Honrubia M., Parras P., Antioxidant activity of edible fungi (truffles and mushrooms): losses during industrial processing. Journal of Food Protection 2002 65 10 1614 1622 2-s2.0-0036801602
19. Beattie K. D., Ulrich R., Grice I. D., Uddin S. J., Blake T. B., Wood K. A., Steele J., Iu F., May T. W., Tiralongo E., Ethanolic and aqueous extracts derived from Australian fungi inhibit cancer cell growth in vitro. Mycologia 2011 103 3 458 465 2-s2.0-80052384352 10.3852/10-121
20. Lee Y. S., Han J. Y., Joo E. Y., Shin S. R., Kim N. W., Study on the anti-tumor effects of extracts from Lepistanuda mushroom. Journal of the Korean Society of Food Science and Nutrition 2005 34 3 317 322
21. Wu Y. Y., Wang H. X., Ng T. B., A Novel Metalloprotease from the Wild Basidiomycete Mushroom Lepista Nuda. Journal of Microbiology and Biotechnology 2011 21 3 256 262 2-s2.0-79953276347 10.4014/jmb.1010.10060
22. Lin C.-C., Chou C.-W., Shiau A.-L., Tu C.-F., Ko T.-M., Chen Y.-L., Yang B.-C., Tao M.-H., Lai M.-D., Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu. Molecular Therapy 2004 10 2 290 301 2-s2.0-4344596965 10.1016/j.ymthe.2004.05.015
23. Wang S.-T., Chang C.-C., Yen M.-C., Tu C.-F., Chu C.-L., Peng Y.-T., Chen D.-Y., Lan J.-L., Lin C.-C., RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency. Gene Therapy 2011 18 4 372 383 2-s2.0-79953800932 10.1038/gt.2010.146
24. Lin C.-C., Yu Y.-L., Shih C.-C., Liu K.-J., Ou K.-L., Hong L.-Z., Chen J. D. C., Chu C.-L., A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunology, Immunotherapy 2011 60 7 1019 1027 2-s2.0-79959743488 10.1007/s00262-011-1016-4
25. Kim G.-Y., Han M.-G., Song Y.-S., Shin B.-C., Shin Y.-I., Lee H.-J., Moon D.-O., Lee C.-M., Kwak J.-Y., Bae Y.-S., Lee J.-D., Park Y.-M., Proteoglycan isolated from Phellinus linteus induces toll-like receptors 2- and 4-mediated maturation of murine dendritic cells via activation of ERK, p38, and NF- B. Biological and Pharmaceutical Bulletin 2004 27 10 1656 1662 2-s2.0-21644466065 10.1248/bpb.27.1656
26. Huang C.-H., Chang C.-C., Lin C.-M., Wang S.-T., Wu M.-T., Li E. I. C., Chang H.-C., Lin C.-C., Promoting effect of Antrodia camphorata as an immunomodulating adjuvant on the antitumor efficacy of HER-2/neu DNA vaccine. Cancer Immunology, Immunotherapy 2010 59 8 1259 1272 2-s2.0-77953230063 10.1007/s00262-010-0852-y
27. Rezzani R., Rodella L., Zauli G., Caimi L., Vitale M., Mouse peritoneal cells as a reservoir of late dendritic cell progenitors. British Journal of Haematology 1999 104 1 111 118 2-s2.0-0032935275 10.1046/j.1365-2141.1999.01138. x
28. Arrighi J.-F., Rebsamen M., Rousset F., Kindler V., Hauser C., A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF- α and contact sensitizers. Journal of Immunology 2001 166 6 3837 3845 2-s2.0-0035869634
29. An H., Yu Y., Zhang M., Xu H., Qi R., Yan X., Liu S., Wang W., Guo Z., Guo J., Qin Z., Cao X., Involvement of ERK, p38 and NF- B signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 2002 106 1 38 45 2-s2.0-0036235478 10.1046/j.1365-2567.2002.01401.x
30. Lu H., Yang Y., Gad E., Wenner C. A., Chang A., Larson E. R., Dang Y., Martzen M., Standish L. J., Disis M. L., Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells. Clinical Cancer Research 2011 17 1 67 76 2-s2.0-78751474671 10.1158/1078-0432.CCR-10-1763
31. Kim H. S., Kim J. Y., Kang J. S., Kim H. M., Kim Y. O., Hong I. P., Lee M. K., Hong J. T., Kim Y., Han S.-B., Cordlan polysaccharide isolated from mushroom Cordyceps militaris induces dendritic cell maturation through toll-like receptor 4 signalings. Food and Chemical Toxicology 2010 48 7 1926 1933 2-s2.0-77953538940 10.1016/j.fct.2010.04.036
32. Tu C.-F., Lin C.-C., Chen M.-C., Ko T.-M., Lin C.-M., Wang Y.-C., Lai M.-D., Autologous neu DNA vaccine can be as effective as xenogenic neu DNA vaccine by altering administration route. Vaccine 2007 25 4 719 728 2-s2.0-33845187439 10.1016/j.vaccine.2006.08.009
33. Lin C.-C., Tu C.-F., Yen M.-C., Chen M.-C., Hsieh W.-J., Chang W.-C., Chang W.-T., Lai M.-D., Inhibitor of heat-shock protein 90 enhances the antitumor effect of DNA vaccine targeting clients of heat-shock protein. Molecular Therapy 2007 15 2 404 410 2-s2.0-33846328749 10.1038/sj.mt.6300014
34. + T cell populations. Annual Review of Immunology 2010 28 445 489 2-s2.0-77952313777 10.1146/annurev-immunol-030409-101212
35. Watford W. T., Moriguchi M., Morinobu A., O'Shea J. J., The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine and Growth Factor Reviews 2003 14 5 361 368 2-s2.0-0042375986 10.1016/S1359-6101(03)00043-1
36. Schroder K., Hertzog P. J., Ravasi T., Hume D. A., Interferon- γ: an overview of signals, mechanisms and functions. Journal of Leukocyte Biology 2004 75 2 163 189 2-s2.0-0842266786 10.1189/jlb.0603252
37. Park H., Li Z., Yang X. O., Chang S. H., Nurieva R., Wang Y.-H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology 2005 6 11 1133 1141 2-s2.0-27544465354 10.1038/ni1261
38. Chamilos G., Ganguly D., Lande R., Gregorio J., Meller S., Goldman W. E., Gilliet M., Kontoyiannis D. P., Generation of IL-23 producing Dendritic Cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of TH-17 responses. PLoS ONE 2010 5 9 2-s2.0-77958552177 10.1371/journal.pone. 0012955 e12955
39. + T cells. The FASEB Journal 2008 22 677
40. Yoshida H., Suzuki M., Sakaguchi R., Tani I., Kotani H., Shudo N., Yoshimura A., Preferential induction of Th17 cells in vitro and in vivo by Fucogalactan from Ganoderma lucidum (Reishi). Biochemical and Biophysical Research Communications 2012 422 1 174 180
41. Carmona E. M., Kottom T. J., Hebrink D. M., Moua T., Singh R. D., Pagano R. E., Limper A. H., Glycosphingolipids mediate pneumocystis cell wall β -glucan activation of the IL-23/IL-17 axis in human dendritic cells. American Journal of Respiratory Cell and Molecular Biology 2012 47 1 50 59
42. Roeleveld D. M., van Nieuwenhuijze A. E., van den Berg W. B., Koenders M. I., The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders. BioDrugs 2013 10.1007/s40259-013-0035-4
43. Ambrosi A., Espinosa A., Wahren-Herlenius M., IL-17: a new actor in IFN-driven systemic autoimmune diseases. European Journal of Immunology 2012 42 9 2274 2284
44. Yang L., Anderson D. E., Baecher-Allan C., Hastings W. D., Bettelli E., Oukka M., Kuchroo V. K., Hafler D. A., IL-21 and TGF- β are required for differentiation of human T H17 cells. Nature 2008 454 7202 350 352 2-s2.0-47549112840 10.1038/nature07021
45. Hirahara K., Ghoreschi K., Laurence A., Yang X.-P., Kanno Y., O'Shea J. J., Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine and Growth Factor Reviews 2010 21 6 425 434 2-s2.0-78649689761 10.1016/j.cytogfr.2010.10.006
46. Libermann T. A., Baltimore D., Activation of interleukin-6 gene expression through the NF- B transcription factor. Molecular and Cellular Biology 1990 10 5 2327 2334 2-s2.0-0025343895
47. Murphy T. L., Cleveland M. G., Kulesza P., Magram J., Murphy K. M., Regulation of interleukin 12 p40 expression through an NF- B half-site. Molecular and Cellular Biology 1995 15 10 5258 5267 2-s2.0-0029143632
48. Collart M. A., Baeuerle P., Vassalli P., Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four B-like motifs and of constitutive and inducible forms of NF- B. Molecular and Cellular Biology 1990 10 4 1498 1506 2-s2.0-0025260779
49. Hinz M., Löser P., Mathas S., Krappmann D., Dörken B., Scheidereit C., Constitutive NF- B maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 2001 97 9 2798 2807 2-s2.0-0035324928 10.1182/blood.V97.9.2798
50. Zou G.-M., Hu W.-Y., LIGHT regulates CD86 expression on dendritic cells through NF- B, but not JNK/AP-1 signal transduction pathway. Journal of Cellular Physiology 2005 205 3 437 443 2-s2.0-26444509700 10.1002/jcp.20420
51. Lin Y.-L., Liang Y.-C., Lee S.-S., Chiang B.-L., Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF- B and p38 mitogen-activated protein kinase pathways. Journal of Leukocyte Biology 2005 78 2 533 543 2-s2.0-23044475016 10.1189/jlb.0804481
52. Boggiatto P. M., Jie F., Ghosh M., Gibson-Corley K. N., Ramer-Tait A. E., Jones D. E., Petersen C. A., Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase, ERK. American Journal of Pathology 2009 174 5 1818 1826 2-s2.0-65649113275 10.2353/ajpath.2009.080905
53. Nakahara T., Uchi H., Urabe K., Chen Q., Furue M., Moroi Y., Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells. International Immunology 2004 16 12 1701 1709 2-s2.0-10844273239 10.1093/intimm/dxh171
54. Yamashita M., Shinnakasu R., Asou H., Kimura M., Hasegawa A., Hashimoto K., Hatano N., Ogata M., Nakayama T., Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway. Journal of Biological Chemistry 2005 280 33 29409 29419 2-s2.0-23844502969 10.1074/jbc.M502333200
55. Nakahara T., Moroi Y., Uchi H., Furue M., Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. Journal of Dermatological Science 2006 42 1 1 11 2-s2.0-33644913374 10.1016/j.jdermsci. 2005.11.004
56. Kaisho T., Akira S., Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends in Immunology 2001 22 2 78 83 2-s2.0-0034927975 10.1016/S1471-4906(00)01811-1
57. Yamanaka D., Motoi M., Ishibashi K., Miura N. N., Adachi Y., Ohno N., Effect of Agaricusbrasiliensis-derived cold water extract on Toll-like receptor 2-dependent cytokine production in vitro. Immunopharmacology and Immunotoxicology 2012 34 4 561 570
58. Kim H. S., Hong J. T., Kim Y., Han S. B., Stimulatory effect of β -glucans on immune cells. Immune Network 2011 11 4 191 195
59. Weinstein S. L., June C. H., DeFranco A. L., Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. Journal of Immunology 1993 151 7 3829 3838 2-s2.0-0027296047
60. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity. Cell 2006 124 4 783 801 2-s2.0-32944464648 10.1016/j.cell.2006.02.015
61. Rice J., Ottensmeier C. H., Stevenson F. K., DNA vaccines: precision tools for activating effective immunity against cancer. Nature Reviews Cancer 2008 8 2 108 120 2-s2.0-38549175830 10.1038/nrc2326
62. Loisel-Meyer S., Foley R., Medin J. A., Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials. Frontiers in Bioscience 2008 13 9 3202 3214 2-s2.0-42649109659 10.2741/2921
63. Bodles-Brakhop A. M., Draghia-Akli R., DNA vaccination and gene therapy: optimization and delivery for cancer therapy. Expert Review of Vaccines 2008 7 7 1085 1101 2-s2.0-51349125266 10.1586/14760584.7.7.1085
64. Rinaldi M., Fioretti D., Iurescia S., Fazio V. M., DNA vaccines: developing new strategies against cancer. Journal of Biomedicine and Biotechnology 2010 2010 16 2-s2.0-77951695279 10.1155/2010/174378 174378